Search results for "PIDE"

showing 10 items of 6055 documents

Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell tra…

2019

Abstract Background There is growing evidence that community‐acquired respiratory virus (CARV) increases the risk of pulmonary invasive fungal disease (IFD) in the allogeneic hematopoietic stem cell transplantation (allo‐HSCT) setting. To date, there is a lack of knowledge regarding the risk factors (RFs), as well as the most critical period for subsequent onset of IFD after CARV infections in allo‐HSCT recipients. Methods In this prospective longitudinal observational CARV survey, we analyzed the effect of CARV on subsequent IFD development in 287 adult allo‐HSCT recipients diagnosed with 597 CARV episodes from December 2013 to December 2018. Multiplex PCR panel assays were used to test CA…

AdultMalemedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentHematopoietic stem cell transplantation030230 surgeryYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsRespiratory virus infectionSurveys and QuestionnairesInternal medicinemedicineHumansTransplantation HomologousLongitudinal StudiesProspective Studiesallogeneic hematopoietic stem cell transplantationRespiratory systemRespiratory Tract InfectionsAgedcommunity-acquired respiratory virusTransplantationcommunity‐acquired respiratory virusbusiness.industryIncidenceIncidence (epidemiology)Hematopoietic Stem Cell TransplantationOriginal Articlesinvasive pulmonary fungal diseaseOdds ratioMiddle AgedTransplant Recipientsinvasive AspergillosisConfidence intervalCommunity-Acquired InfectionsInfectious DiseasesInvasive fungal diseaseRespiratory virusFemaleOriginal Article030211 gastroenterology & hepatologybusinessInvasive Fungal Infectionsimmunodeficiency score indexTransplant Infectious Disease
researchProduct

Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients

2020

Abstract Diagnosis, treatment, and management of invasive mould infections (IMI) are challenged by several risk factors, including local epidemiological characteristics, the emergence of fungal resistance and the innate resistance of emerging pathogens, the use of new immunosuppressants, as well as off-target effects of new oncological drugs. The presence of specific host genetic variants and the patient's immune system status may also influence the establishment of an IMI and the outcome of its therapy. Immunological components can thus be expected to play a pivotal role not only in the risk assessment and diagnosis, but also in the treatment of IMI. Cytokines could improve the reliability…

AdultMalemedicine.medical_specialtyTreatment responseAntifungal Agentshemato-oncological malignanciesAspergillosismucormycosis03 medical and health sciencesImmunocompromised HostImmune systemSDG 3 - Good Health and Well-beingInternal medicineNeoplasmsEpidemiologyimmunological statusmedicineHumansIntensive care medicine030304 developmental biologyAgedAged 80 and over0303 health sciencesHematology030306 microbiologybusiness.industryinvasive pulmonary aspergillosishematologyMucormycosisCancerReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseInfectious Diseaseshemato-oncological malignancies; hematology; immunological status; invasive pulmonary aspergillosis; mucormycosisAcademicSubjects/SCI00960FemaleOriginal ArticleRisk assessmentbusinessAcademicSubjects/MED00010Invasive Fungal Infections
researchProduct

Prevention and early detection of tuberculosis

1996

1,570 subjects with known TB contacts (active TB, old TB and primary infection) and individuals with no known contacts but belonging to 'defined TB risk groups' were screened at the Department of Tuberculosis Prevention at the La Fe Hospital in Valencia. The total infection rate was 40.13% and active TBC was diagnosed in 2.23% of the population screened. Infection and disease rates were significant in all the groups examined, showing the need for correct screening not only for active TB contacts but also for child primary infection contacts, old TB cases not previously screened and subjects with no known contacts but belonging to a 'TB risk group'.

AdultMalemedicine.medical_specialtyTuberculosisAdolescentEpidemiologyPopulationEarly detectionRisk groupsInternal medicineActive tbEpidemiologyPrevalencemedicineHumansMass ScreeningChildeducationLungTuberculosis PulmonaryAgedAged 80 and overeducation.field_of_studyTuberculin Testbusiness.industryTuberculosis preventionPublic healthSputumInfantMycobacterium tuberculosisMiddle Agedmedicine.diseaseRadiographySpainChild PreschoolImmunologyFemaleContact TracingbusinessEuropean Journal of Epidemiology
researchProduct

[Tuberculosis epidemiology in area 15 of the Spanish autonomous community of Valencia: evolution from 1987 through 2001].

2005

Objectives TO describe the evolution of tuberculosis epidemiology in Area 15 of the Autonomous Community of Valencia. Material and Methods Cases of tuberculosis were identified by active case finding in Area 15 from January 1987 through December 2001. Clinical and epidemiological data were extracted from case records and a patient interview. Results Four hundred seventy-six diagnosed cases of mycobacterial infection were identified (459 tuberculosis, 16 atypical, and 1 mixed); 423 tuberculosis patients were residents of Area 15. The mean annual incidence rate was 24.6/100 000 population, representing a rate decrease of 41.5% from 1990. The most frequent risk factors were smoking (38%), alco…

AdultMalemedicine.medical_specialtyTuberculosisTime FactorsAdolescentPopulationAntitubercular AgentsHIV InfectionsAnnual incidenceCohort StudiesSex FactorsRisk FactorsInternal medicinePandemicEpidemiologymedicineHumansTuberculosiseducationChildTuberculosis PulmonaryAgededucation.field_of_studyLungbusiness.industryIncidence (epidemiology)SmokingAge FactorsInfant NewbornInfantGeneral MedicineIsoniazid resistanceLength of StayMiddle Agedmedicine.diseaseHospitalizationAlcoholismmedicine.anatomical_structureSpainChild PreschoolImmunologyFemaleRadiography ThoracicbusinessArchivos de bronconeumologia
researchProduct

Management of symptomatic benign prostatic hyperplasia in southern Italy: a retrospective analysis of the Sicilian-Calabrian Society of Urology (SSCU…

2002

<i>Introduction:</i> The availability of new pharmacological and surgical options is responsible for important changes in the management of symptomatic benign prostate hyperplasia (BPH). The Sicilian-Calabrian Society of Urology performed a retrospective survey to assess the management of BPH in southern Italy in 1997 and 1998. <i>Patients and Methods:</i> A 3-page questionnaire was sent to the 36 urological units of these two regions. The real number of patients treated was required. The numbers were checked with data obtained from the Health Regional Offices. <i>Results:</i> Twenty-six urological units (72.3%) replied. Almost all patients underwent urin…

AdultMalemedicine.medical_specialtyUrinalysisUrologymedicine.medical_treatmentUrologyProstatic HyperplasiaTransurethral prostatectomyProstateEpidemiologymedicineHumansMinimally Invasive Surgical ProceduresTransurethral resection of the prostateAgedRetrospective StudiesAged 80 and overProstatectomymedicine.diagnostic_testUrinary retentionbusiness.industryMiddle Agedmedicine.anatomical_structureItalyInternational Prostate Symptom Scoremedicine.symptombusinessOpen ProstatectomyUrologia internationalis
researchProduct

Pancreatic Fistulae after Urologic Surgery - A Single Centre Experience.

2015

<b><i>Introduction:</i></b> To evaluate incidence, symptoms and management of postoperative pancreatic fistula (POPF) after urologic surgery based on our experience. <b><i>Material and Methods:</i></b> Database was searched for clinically evident POPF after urologic surgery between 1998 and 2014. Fistulae were graded using the POPF classification. Clinical course of every POPF patient was evaluated. <b><i>Results:</i></b> During this time, 3,200 surgeries for renal, adrenal and retroperitoneal pathologies were performed. Twelve POPF occurred postoperatively in this series. Eight fistulae were POPF grade A, 3 POPF grade …

AdultMalemedicine.medical_specialtyUrologyMalignancySepsisPancreatic FistulaYoung AdultmedicineUrologic surgeryHumansAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceMiddle Agedmedicine.diseaseSurgerySingle centrePancreatic fistulaUrologic Surgical ProceduresFemalePositive Surgical MarginbusinessComplicationUrologia internationalis
researchProduct

Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpat…

2007

Abstract: Purpose: We evaluated the prevalence and estimated the incidence and risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy. Materials and Methods: From January to June 2006 patients from 28 Italian urological centers who were between 25 and 50 years old with symptoms of chronic prostatitis/chronic pelvic pain syndrome were consecutively enrolled in this prospective epidemiological case-control study. A total of 152 subjects of similar age, race and area of origin who were investigated for infertile couples but were otherwise healthy served as controls. All subjects provided a medical history and underwent different symptom sco…

AdultMalemedicine.medical_specialtyUrologyProstatitisPelvic PainHospitals SpecialSeverity of Illness IndexSettore MED/24 - UrologiaChronic prostatitis/chronic pelvic pain syndromeRisk Factorsprostate prostatitis quality of life pain life styleInternal medicineSeverity of illnessAmbulatory CarePrevalencemedicineHumansMedical historyRisk factorbusiness.industryIncidenceIncidence (epidemiology)Pelvic painMiddle AgedPrognosismedicine.diseaseProstatitisSurgeryChronic bacterial prostatitisItalyCase-Control StudiesChronic DiseaseQuality of Lifemedicine.symptombusinessJournal of Urology
researchProduct

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

2009

Summary Background We analysed 5-year treatment with agalsidase alfa enzyme replacement therapy in patients with Fabry's disease who were enrolled in the Fabry Outcome Survey observational database (FOS). Methods Baseline and 5-year data were available for up to 181 adults (126 men) in FOS. Serial data for cardiac mass and function, renal function, pain, and quality of life were assessed. Safety and sensitivity analyses were done in patients with baseline and at least one relevant follow-up measurement during the 5 years (n=555 and n=475, respectively). Findings In patients with baseline cardiac hypertrophy, treatment resulted in a sustained reduction in left ventricular mass (LVM) index af…

AdultMalemedicine.medical_specialtyUrologyRenal functionKidney Function TestsMuscle hypertrophyQuality of lifeSurveys and QuestionnairesEpidemiologymedicineHumansRegistriesPain MeasurementVascular diseasebusiness.industryGeneral MedicineEnzyme replacement therapymedicine.diseaseFabry's diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomealpha-GalactosidaseHeart Function TestsQuality of LifeFabry DiseaseFemalebusinessThe Lancet
researchProduct

Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph nod…

2009

OBJECTIVE To investigate the associations between different overall or topographically restricted lymph node (LN) variables and cancer-specific survival (CSS) after radical cystectomy (RC) and extended LN dissection (LND) with curative intent in patients with LN-positive bladder cancer. PATIENTS AND METHODS Between 2001 and 2006, 152 patients had RC with standardized extended LND for bladder cancer with curative intent. Patients with positive LNs were stratified according to the median of the LN variables (LNs removed, number of positive LNs, LN density). CSS was related to overall and topographically restricted LN variables, e.g. different levels of LND, and relationships were tested by un…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyCystectomymedicineCarcinomaHumansLymph nodeAgedAged 80 and overCarcinoma Transitional CellBladder cancerbusiness.industryHazard ratioCancerMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryTreatment Outcomemedicine.anatomical_structureUrinary Bladder NeoplasmsLymphatic MetastasisLymph Node ExcisionFemaleLymphadenectomyEpidemiologic MethodsbusinessBJU International
researchProduct

Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany

2021

Background. Comprehensive data on the epidemiology and comorbidities of chronic urticaria (CU) in Germany are either limited, or not contemporary. Objectives. To investigate the epidemiology of CU, overall comorbidities and healthcare resource utilized by patients with CU in Germany, using an anonymized statutory health insurance (SHI) database. Methods. Anonymized SHI claims research database of the Institute for Applied Health Research, Berlin [InGef] (01 January 2015-30 September 2018) was used to analyse insured individuals with a confirmed diagnosis of CU (ICD-10-GM codes). Twelve-month diagnosed prevalence and incidence, comorbidities (vs. atopic dermatitis and psoriasis), and healthc…

AdultMalemedicine.medical_specialtyUrticariaPopulation610Dermatologychronic urticariaGermanyPsoriasisInternal medicineHealth careEpidemiologyHumansMedicineddc:610ChildeducationChronic urticariaeducation.field_of_studybusiness.industryIncidence (epidemiology)healthcare utilizationAtopic dermatitisPatient Acceptance of Health Caremedicine.diseasecomorbidityInfectious DiseasesHealthcare utilizationChronic DiseaseFemaleepidemiologybusiness600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
researchProduct